MK-677

Also known as: Ibutamoren, Nutrobal, L-163,191

Clinical Trials
GH Secretagogue

An orally active growth hormone secretagogue that mimics ghrelin. Not a peptide technically, but frequently discussed alongside GH peptides due to similar effects.

Share:

Mechanism of Action

MK-677 binds to ghrelin receptors (GHSR) in the brain, stimulating sustained GH release and increasing IGF-1 levels. Unlike injectable GHRPs, it's orally bioavailable and has a long half-life providing 24-hour GH elevation.

Research Summary

Studies show significant increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. Research in elderly shows reversal of diet-induced nitrogen wasting. Long-term studies demonstrate sustained efficacy.

Clinical Status:Investigational - Phase II trials completed
Trial Progress:Phase II
Pre
I
II
III
IV
FDA

Research Protocols

Note: Doses from research studies

Common Doses

  • 10-25 mg daily
  • 25 mg most common

Duration

8-12 weeks or longer

Administration

Oral

Side Effects & Considerations

  • Increased appetite
  • Water retention
  • Lethargy initially
  • Numbness/tingling
  • Elevated blood glucose possible
  • Potential prolactin increase

References

Want updates on MK-677 research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.